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Abstract
Introduction: Azole-resistant Aspergillus fumigatus isolates have emerged as a major source
of life threatening aspergillosis in hospitalized patients and these infections have been
associated with significant morbidity and mortality even when properly diagnosed and
treated. The decreased use of azole drugs in patients and in the environment is clearly
important to decrease the emergence of azole-resistant A- fumigatus. In addition, combination
therapy as a crucial approach to overcome challenges in treatment of patients with azole-
resistant Aspergillus infection can be considered. The aim of this study was to determine the
in vitro susceptibility testing alone and in combination of amphotericin B with voriconazole,
amphotericin B with caspofungin, itraconazole with caspofungin and voriconazole with
caspofungin against azole-resistant and azole-susceptible A. fumigatus clinical and
environmental isolates.
Material and methods: A total of 30 azole-resistant and 20 azole-susceptible A. fumigatus
strains, were tested. The in vitro susceptibility testing of amphotericin B, Itraconazole,
voriconazole and caspofungin were tested. In vitro combination between of amphotericin B
with voriconazole, amphotericin B with caspofungin, itraconazole with caspofungin and
voriconazole with caspofungin against azole-resistant and azole-susceptible A. fumigatus
clinical and environmental isolates were tested by using a checkerboard method based on the
microdilution broth reference technique (M38-A2) of the Clinical and Laboratory Standards
Institute (CLSD.
Results: The range of amphotericin B, itraconazole, voriconazole MICs and caspofungin
MECs when tested alone were 0.125 
- 
4 trt"g/ml,0.063 - >16 1,t91m1,0.031 - 8 pglml and 0.008
- 0.5 pglml, respectively. The interaction between amphotericin B with voriconazole (FICI
range: 0.21 - 0.5), amphotericin B with caspofungin (FICI range:0.18 - 0.5) were synergistic
and combination of itraconazole with caspofungin (FICI range: 0.75 
- 
2.5) and voriconazole
with caspofungin (FICI range: A.75 
- 
2) were indifferent.
Discussion: Alternative antifungal strategies including combination therapy to avoid further
emergence of azole-resistance, at the first suspicion of invasive aspergillosis in critical ill
patients. In conclusio n, in vitro interaction of amphotericin-B with vorico nazole, amphotericin
B with caspofungin were synergistic against azole-resistant and azole susceptible A. fumigatus
isolates. An increased likelihood that the resistant A. fumigatus will be susceptible to at least
one of the components makes them a suitable option as an empiric combination regimen.
I;
i
More in vitro and in vivo studies are necessary to address questions regarding amphotericin B
with voriconazole and caspofungin combination therapy.
Keywords: In vitro combination, synergistic, azole-resistant and azole-susceptible A-
fumigatus
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